Pacific Biosciences of California, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Pacific Biosciences of California, Inc. (PACB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$3.52 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-25
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was -$3.52M, a 543.25% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $793.00K, a 47.59% decline from fiscal 2023.
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was $1.51M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | -$3.52M 10-K · filed 2026-02-25 |
| 2024-12-31 | $793.00K 10-K · filed 2026-02-25 |
| 2023-12-31 | $1.51M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |